• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Maternally-Derived Antibodies Protect against Challenge with Highly Pathogenic Avian Influenza Virus of the H7N3 Subtype

tetano

Editor, Senior Moderator
Vaccines (Basel). 2019 Oct 30;7(4). pii: E163. doi: 10.3390/vaccines7040163. [h=1]Maternally-Derived Antibodies Protect against Challenge with Highly Pathogenic Avian Influenza Virus of the H7N3 Subtype.[/h]
Cardenas-Garcia S[SUP]1[/SUP], Ferreri L[SUP]2[/SUP], Wan Z[SUP]3[/SUP], Carnaccini S[SUP]4[/SUP], Geiger G[SUP]5[/SUP], Obadan AO[SUP]6[/SUP], Hofacre CL[SUP]7[/SUP], Rajao D[SUP]8[/SUP], Perez DR[SUP]9[/SUP].
[h=3]Author information[/h] 1 Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA. stivalis@uga.edu. 2 Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA. lferreri@uga.edu. 3 Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA. 15952707826@163.com. 4 Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA. scarnaccini@uga.edu. 5 Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA. imginger@uga.edu. 6 Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA. willowsgal@gmail.com. 7 Southern Poultry Research Group, Watkinsville, GA 30677, USA. clhofacre@thesprgroup.com. 8 Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA. daniela.rajao@uga.edu. 9 Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA. dperez1@uga.edu.

[h=3]Abstract[/h] Vaccination of hens against influenza leads to the transfer of protective maternally-derived antibodies (MDA) to hatchlings. However, little is known about the transfer of H7N3 vaccine-induced MDA. Here, we evaluated transfer, duration, and protective effect of MDA in chickens against H7N3 HPAIV. To generate chickens with MDA (MDA (+)), 15-week-old White Leghorn hens were vaccinated and boosted twice with an inactivated H7N3 low pathogenic avian influenza virus vaccine, adjuvanted with Montanide ISA 71 VG. One week after the final boost, eggs were hatched. Eggs from non-vaccinated hens were hatched for chickens without MDA (MDA (-)). Both MDA (+) and MDA (-) hatchlings were monitored weekly for antibody levels. Anti-HA MDA were detected by hemagglutination inhibition assay mostly until day 7 post-hatch. However, anti-nucleoprotein MDA were still detected three weeks post-hatch. Three weeks post-hatch, chickens were challenged with 10[SUP]6[/SUP] EID[SUB]50[/SUB]/bird of Mexican-origin H7N3 HPAIV. Interestingly, while 0% of the MDA (-) chickens survived the challenge, 95% of the MDA (+) chickens survived. Furthermore, virus shedding was significantly reduced by day 5 post-challenge in the MDA (+) group. In conclusion, MDA confers partial protection against mortality upon challenge with H7N3 HPAIV, as far as three weeks post-hatch, even in the absence of detectable anti-HA antibodies, and reduce virus shedding after challenge.


[h=4]KEYWORDS:[/h] H7N3; highly pathogenic avian influenza virus; maternally-derived antibodies; protection; vaccination of chickens

PMID: 31671571 DOI: 10.3390/vaccines7040163
 
Back
Top Bottom